JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB108387

Anti-Tau (phospho S202) antibody [EPR2402]

2

(2 Reviews)

|

(22 Publications)

Rabbit Recombinant Monoclonal TAU phospho S202 antibody. Suitable for Dot, WB and reacts with Synthetic peptide, Mouse, Rat, Human samples. Cited in 22 publications.

View Alternative Names

MAPTL, MTBT1, TAU, MAPT, Microtubule-associated protein tau, Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau, MAPTL, MTBT1, TAU, MAPT, Microtubule-associated protein tau, Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau

4 Images
Western blot - Anti-Tau (phospho S202) antibody [EPR2402] (AB108387)
  • WB

Supplier Data

Western blot - Anti-Tau (phospho S202) antibody [EPR2402] (AB108387)

The molecular weight observed is consistent with what has been described in the literature (PMID : 28382304, 32692785 and 30120733).

Blocking and diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Tau (phospho S202) antibody [EPR2402] (ab108387) at 1/1000 dilution

Lane 1:

Human brain lysate at 15 µg

Lane 2:

Human brain lysate then the membrane treated with Alkaline Phosphatase for 1 hour at 15 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Predicted band size: 78 kDa

Observed band size: 32-72 kDa

false

Western blot - Anti-Tau (phospho S202) antibody [EPR2402] (AB108387)
  • WB

Supplier Data

Western blot - Anti-Tau (phospho S202) antibody [EPR2402] (AB108387)

The molecular weight observed is consistent with what has been described in the literature (PMID : 28382304, 32692785 and 30120733).

Blocking and diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Tau (phospho S202) antibody [EPR2402] (ab108387) at 1/1000 dilution

Lane 1:

Rat hippocampus lysate at 15 µg

Lane 2:

Rat hippocampus lysate then the membrane treated with Alkaline Phosphatase for 1 hour at 15 µg

Lane 3:

Rat cerebral cortex lysate at 15 µg

Lane 4:

Rat cerebral cortex lysate then the membrane treated with Alkaline Phosphatase for 1 hour at 15 µg

Lane 5:

Mouse hippocampus lysate at 15 µg

Lane 6:

Mouse hippocampus lysate then the membrane treated with Alkaline Phosphatase for 1 hour at 15 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Predicted band size: 78 kDa

Observed band size: 32-72 kDa

false

Dot Blot - Anti-Tau (phospho S202) antibody [EPR2402] (AB108387)
  • Dot

Supplier Data

Dot Blot - Anti-Tau (phospho S202) antibody [EPR2402] (AB108387)

Dot blot analysis using 1/1000 dilution ab108387 and Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary at 1/100000 dilution.

Blocking and diluting buffer : 5% NFDM/TBST

Lane 1 : Tau non-phospho peptide

Lane 2 : Tau S199 phospho peptide

Lane 3 : Tau S202 phospho peptide

Lane 4 : Tau S199+S202 phospho peptide

Exposure time : 3 minutes

Western blot - Anti-Tau (phospho S202) antibody [EPR2402] (AB108387)
  • WB

CiteAb

Western blot - Anti-Tau (phospho S202) antibody [EPR2402] (AB108387)

Tau (phospho S202) western blot using anti-Tau (phospho S202) antibody [EPR2402] ab108387. Publication image and figure legend from Sun, W., Lee, S., et al., 2016, Sci Rep, PubMed 27708431.

ab108387 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab108387 please see the product overview.

MB reduced Tau phosphorylation by endogenous kinases in 293T cells.(a) Representative immunoblot of lysates from 293T cells transfected with 4R2N Tau. Transfected cells were treated with AC, MB and OS for 3 h at concentrations indicated in the panel. The levels of pTau S262, S396, S214, S202 and total Tau were reported with β-actin as the loading control. (b–e) Quantification of the ratio of pTau to total Tau presented as the percent of the level found in cells transfected with Tau but without drug treatment. Results are mean ± SD (n = 3). *0.01 < p < 0.05; **0.001 < p < 0.01 ***p < 0.001. Student's t test is conducted between corresponding values in AC and OS or MB and OS group.

false

  • Carrier free

    Anti-Tau (phospho S202) antibody [EPR2402] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR2402

Isotype

IgG

Carrier free

No

Reacts with

Human, Mouse, Rat

Applications

WB, Dot

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

Stimulation may be required to allow detection of the phosphorylated protein. Please see images below for recommended treatment conditions and positive controls.

The specificity of this antibody refers to P10636-8.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "Dot" : {"fullname" : "Dot Blot", "shortname":"Dot"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Mouse": { "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Rat": { "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Synthetic peptide": { "Dot-species-checked": "testedAndGuaranteed", "Dot-species-dilution-info": "1/1000", "Dot-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Tau also known as microtubule-associated protein Tau (MAPT) plays an important role in stabilizing microtubules in neuronal cells. Tau is primarily found in the central nervous system but also exists in peripheral neurons. Human Tau protein comes in six isoforms due to alternative splicing with molecular weights ranging from 48 kDa to 67 kDa. This protein predominantly locates in the axons of neurons where it maintains the stability of microtubule tracks necessary for axonal transport.
Biological function summary

Tau is involved in the assembly and stabilization of microtubules essential for maintaining neuronal structure. It interacts with microtubule-binding domains (MBD) to bind and bundle microtubules facilitating intracellular transport. Tau forms a part of the neuronal cytoskeleton complex working closely with other cytoskeletal proteins to preserve the proper axonal transport and function. Abnormally phosphorylated Tau often termed phospho-Tau disrupts this complex affecting microtubule stability.

Pathways

Tau has critical involvement in several signaling cascades such as the microtubule-binding and transport pathways. Glycogen synthase kinase 3 beta (GSK3β) and cyclin-dependent kinase 5 (CDK5) frequently phosphorylate Tau controlling its interaction with microtubules. Phosphorylated Tau accumulates leading to the formation of neurofibrillary tangles often observed in neurodegenerative conditions. Additionally Tau interacts with GAPDH impacting cellular energy regulation through potential pathway cross-talk involving oxidative stress responses.

Tau is closely associated with Alzheimer's disease and frontotemporal dementia. In Alzheimer's disease hyperphosphorylated Tau aggregates into paired helical filaments forming neurofibrillary tangles while similar aggregates are observed in frontotemporal dementia. In these conditions Tau links to amyloid precursor protein (APP) where misregulated phosphorylation-driven interactions contribute to neurodegeneration. Identifying phospho-Tau and its altered interactions with related proteins aids in understanding and potentially treating these disorders.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed : 21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed : 21985311, PubMed : 32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
See full target information MAPT phospho S202

Additional targets

MAPT phospho S202

Publications (22)

Recent publications for all applications. Explore the full list and refine your search

Brain informatics 12:26 PubMed41037159

2025

Regulation of tau protein by circCwc27: shared pathogenic mechanisms in type 2 diabetes mellitus and Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Keying Fang,Bin Jiao,Lu Shen,Shilin Luo

eLife 13: PubMed40762561

2025

The novel role of Kallistatin in linking metabolic syndromes and cognitive memory deterioration by inducing amyloid-β plaques accumulation and tau protein hyperphosphorylation.

Applications

Unspecified application

Species

Unspecified reactive species

Weiwei Qi,Yanlan Long,Ziming Li,Zhen Zhao,Jinhui Shi,Wanting Xie,Laijian Wang,Yandan Tan,Ti Zhou,Minting Liang,Ping Jiang,Bin Jiang,Xia Yang,Guoquan Gao

The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 29:215-225 PubMed39806787

2025

Microglial galectin-3 increases with aging in the mouse hippocampus.

Applications

Unspecified application

Species

Unspecified reactive species

Hyun Joo Shin,So Jeong Lee,Hyeong Seok An,Ha Nyeoung Choi,Eun Ae Jeong,Jaewoong Lee,Kyung Eun Kim,Bong-Hoi Choi,Seung Pil Yun,Dawon Kang,Sang Soo Kang,Gu Seob Roh

Nature communications 14:6670 PubMed37865646

2023

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Xingyu Zhang,Li Tang,Jiaolong Yang,Lanxia Meng,Jiehui Chen,Lingyan Zhou,Jiangyu Wang,Min Xiong,Zhentao Zhang

Journal of neurochemistry 167:441-460 PubMed37814468

2023

Effects of anti-tau immunotherapy on reactive microgliosis, cerebral endotheliopathy, and cognitive function in an experimental model of cerebral malaria.

Applications

Unspecified application

Species

Unspecified reactive species

Oscar B Akide Ndunge,Henry J Shikani,Minxian Dai,Brandi D Freeman,Mahalia S Desruisseaux

Science advances 8:eadd2577 PubMed36459557

2022

Treatment of epilepsy using a targeted p38γ kinase gene therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Nicolle Morey,Magdalena Przybyla,Julia van der Hoven,Yazi D Ke,Fabien Delerue,Janet van Eersel,Lars M Ittner

Cells 11: PubMed36359919

2022

Branched-Chain Amino Acids Are Linked with Alzheimer's Disease-Related Pathology and Cognitive Deficits.

Applications

Unspecified application

Species

Unspecified reactive species

Md Abu Bakkar Siddik,Caitlyn A Mullins,Alyssa Kramer,Harsh Shah,Ritchel B Gannaban,Masoud Zabet-Moghaddam,Ryan M Huebinger,Vijay K Hegde,Sheba M J MohanKumar,Puliyur S MohanKumar,Andrew C Shin

Science advances 8:eabl8809 PubMed35857446

2022

Alzheimer's disease: Ablating single master site abolishes tau hyperphosphorylation.

Applications

Unspecified application

Species

Unspecified reactive species

Kristie Stefanoska,Mehul Gajwani,Amanda R P Tan,Holly I Ahel,Prita R Asih,Alexander Volkerling,Anne Poljak,Arne Ittner

Scientific reports 12:6839 PubMed35477957

2022

High altitude is associated with pTau deposition, neuroinflammation, and myelin loss.

Applications

Unspecified application

Species

Unspecified reactive species

Diego Iacono,Erin K Murphy,Paul M Sherman,Holly Chapapas,Bianca Cerqueira,Christine Christensen,Daniel P Perl,John Sladky

NeuroSci 3:166-185 PubMed39483368

2022

Localization of Thioredoxin-Interacting Protein in Aging and Alzheimer's Disease Brains.

Applications

Unspecified application

Species

Unspecified reactive species

Haruka Tsubaki,Anarmaa Mendsaikhan,Undral Buyandelger,Ikuo Tooyama,Douglas G Walker
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com